Aytu BioPharma Inc (AYTU)
3.04
-0.04
(-1.30%)
USD |
NASDAQ |
Mar 28, 16:00
3.09
+0.05
(+1.64%)
After-Hours: 20:00
Aytu BioPharma Total Liabilities (Quarterly): 98.40M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 98.40M |
September 30, 2023 | 100.72M |
June 30, 2023 | 97.11M |
March 31, 2023 | 106.30M |
December 31, 2022 | 95.62M |
September 30, 2022 | 96.09M |
June 30, 2022 | 93.32M |
March 31, 2022 | 107.68M |
December 31, 2021 | 118.29M |
September 30, 2021 | 116.23M |
June 30, 2021 | 128.10M |
March 31, 2021 | 128.41M |
December 31, 2020 | 54.05M |
September 30, 2020 | 50.21M |
June 30, 2020 | 58.28M |
March 31, 2020 | 73.25M |
December 31, 2019 | 57.39M |
September 30, 2019 | 28.70M |
June 30, 2019 | 27.63M |
March 31, 2019 | 22.30M |
December 31, 2018 | 22.50M |
September 30, 2018 | 7.855M |
June 30, 2018 | 7.636M |
March 31, 2018 | 10.62M |
December 31, 2017 | 15.83M |
Date | Value |
---|---|
September 30, 2017 | 14.89M |
June 30, 2017 | 11.00M |
March 31, 2017 | 7.395M |
December 31, 2016 | 11.06M |
September 30, 2016 | 13.01M |
June 30, 2016 | 14.26M |
March 31, 2016 | 4.420M |
December 31, 2015 | 9.151M |
September 30, 2015 | 7.951M |
June 30, 2015 | 2.569M |
March 31, 2015 | 9.650M |
February 28, 2015 | 0.0609M |
November 30, 2014 | 0.0552M |
August 31, 2014 | 0.0505M |
May 31, 2014 | 0.0495M |
February 28, 2014 | 0.1534M |
November 30, 2013 | 0.1334M |
August 31, 2013 | 0.1205M |
May 31, 2013 | 0.1155M |
February 28, 2013 | 0.1079M |
November 30, 2012 | 0.0941M |
August 31, 2012 | 0.0824M |
May 31, 2012 | 0.069M |
February 29, 2012 | 0.0657M |
November 30, 2011 | 0.0664M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
22.30M
Minimum
Mar 2019
128.41M
Maximum
Mar 2021
82.90M
Average
95.86M
Median
Total Liabilities (Quarterly) Benchmarks
CEL-SCI Corp | 16.06M |
AIM ImmunoTech Inc | 5.259M |
IGC Pharma Inc | 2.206M |
NovaBay Pharmaceuticals Inc | 5.815M |
Protalix BioTherapeutics Inc | 50.86M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 131.25M |
Shareholders Equity (Quarterly) | 32.85M |
Debt to Equity Ratio | 0.4883 |
Current Ratio | 1.112 |
Net Debt Paydown Yield | 8.26% |